Literature DB >> 17244613

Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta.

Laura A Solt1, Lisa A Madge, Jordan S Orange, Michael J May.   

Abstract

Activation of NF-kappaB by the pro-inflammatory cytokines tumor necrosis factor (TNF) and interleukin-1 (IL-1) requires the IkappaB kinase (IKK) complex, which contains two kinases named IKKalpha and IKKbeta and a critical regulatory subunit named NEMO. Although we have previously demonstrated that NEMO associates with both IKKs, genetic studies reveal that only its interaction with IKKbeta is required for TNF-induced NF-kappaB activation. To determine whether NEMO and IKKalpha can form a functional IKK complex capable of activating the classical NF-kappaB pathway in the absence of IKKbeta, we utilized a panel of mouse embryonic fibroblasts (MEFs) lacking each of the IKK complex subunits. This confirmed that TNF-induced IkappaBalpha degradation absolutely requires NEMO and IKKbeta. In contrast, we consistently observed intact IkappaBalpha degradation and NF-kappaB activation in response to IL-1 in two separate cell lines lacking IKKbeta. Furthermore, exogenously expressed, catalytically inactive IKKbeta blocked TNF- but not IL-1-induced IkappaBalpha degradation in wild-type MEFs, and reconstitution of IKKalpha/beta double knockout cells with IKKalpha rescued IL-1- but not TNF-induced NF-kappaB activation. Finally, we have shown that incubation of IKKbeta-deficient MEFs with a cell-permeable peptide that blocks the interaction of NEMO with the IKKs inhibits IL-1-induced NF-kappaB activation. Our results therefore demonstrate that NEMO and IKKalpha can form a functional IKK complex that activates the classical NF-kappaB pathway in response to IL-1 but not TNF. These findings further suggest NEMO differentially regulates the fidelity of the IKK subunits activated by distinct upstream signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244613      PMCID: PMC2824644          DOI: 10.1074/jbc.M609613200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase.

Authors:  Y Hu; V Baud; M Delhase; P Zhang; T Deerinck; M Ellisman; R Johnson; M Karin
Journal:  Science       Date:  1999-04-09       Impact factor: 47.728

Review 2.  The two NF-kappaB activation pathways and their role in innate and adaptive immunity.

Authors:  Giuseppina Bonizzi; Michael Karin
Journal:  Trends Immunol       Date:  2004-06       Impact factor: 16.687

Review 3.  Signaling to NF-kappaB.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

4.  Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.

Authors:  Q Li; D Van Antwerp; F Mercurio; K F Lee; I M Verma
Journal:  Science       Date:  1999-04-09       Impact factor: 47.728

5.  Nuclear role of I kappa B Kinase-gamma/NF-kappa B essential modulator (IKK gamma/NEMO) in NF-kappa B-dependent gene expression.

Authors:  Udit N Verma; Yumi Yamamoto; Shashi Prajapati; Richard B Gaynor
Journal:  J Biol Chem       Date:  2003-11-03       Impact factor: 5.157

6.  Characterization of the Ikappa B-kinase NEMO binding domain.

Authors:  Michael J May; Ralf B Marienfeld; Sankar Ghosh
Journal:  J Biol Chem       Date:  2002-09-19       Impact factor: 5.157

7.  A novel ubiquitin-like domain in IkappaB kinase beta is required for functional activity of the kinase.

Authors:  Michael J May; Signe E Larsen; Jae Hyuck Shim; Lisa A Madge; Sankar Ghosh
Journal:  J Biol Chem       Date:  2004-08-19       Impact factor: 5.157

8.  Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression.

Authors:  Yumi Yamamoto; Udit N Verma; Shashi Prajapati; Youn-Tae Kwak; Richard B Gaynor
Journal:  Nature       Date:  2003-06-05       Impact factor: 49.962

9.  Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways.

Authors:  Jürgen R Müller; Ulrich Siebenlist
Journal:  J Biol Chem       Date:  2003-01-28       Impact factor: 5.157

10.  Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.

Authors:  Eijiro Jimi; Kazuhiro Aoki; Hiroaki Saito; Fulvio D'Acquisto; Michael J May; Ichiro Nakamura; Testuo Sudo; Takefumi Kojima; Fujio Okamoto; Hidefumi Fukushima; Koji Okabe; Keiichi Ohya; Sankar Ghosh
Journal:  Nat Med       Date:  2004-05-23       Impact factor: 53.440

View more
  37 in total

1.  NF-κB in Aging and Disease.

Authors:  Jeremy S Tilstra; Cheryl L Clauson; Laura J Niedernhofer; Paul D Robbins
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

Review 2.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

Review 3.  Microglia mediated neuroinflammation - signaling regulation and therapeutic considerations with special reference to some natural compounds.

Authors:  Yue-Yi Yao; Eng-Ang Ling; Di Lu
Journal:  Histol Histopathol       Date:  2020-07-14       Impact factor: 2.303

4.  Targeting of NF-κB to Dendritic Spines Is Required for Synaptic Signaling and Spine Development.

Authors:  Erica C Dresselhaus; Matthew C H Boersma; Mollie K Meffert
Journal:  J Neurosci       Date:  2018-03-19       Impact factor: 6.167

Review 5.  Cell penetrating peptide inhibitors of nuclear factor-kappa B.

Authors:  J S Orange; M J May
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

Review 6.  Proinflammatory stem cell signaling in cardiac ischemia.

Authors:  Jeremy L Herrmann; Troy A Markel; Aaron M Abarbanell; Brent R Weil; Meijing Wang; Yue Wang; Jiangning Tan; Daniel R Meldrum
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

7.  Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kappaB essential modulator binding domain peptides.

Authors:  Eric T Baima; Julia A Guzova; Sumathy Mathialagan; Eva E Nagiec; Medora M Hardy; Lily R Song; Sheri L Bonar; Robin A Weinberg; Shaun R Selness; Scott S Woodard; Jill Chrencik; William F Hood; John F Schindler; Nandini Kishore; Gabriel Mbalaviele
Journal:  J Biol Chem       Date:  2010-02-18       Impact factor: 5.157

8.  TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB.

Authors:  Y Ye; L M Pringle; A W Lau; D N Riquelme; H Wang; T Jiang; D Lev; A Welman; G A Blobel; A M Oliveira; M M Chou
Journal:  Oncogene       Date:  2010-04-26       Impact factor: 9.867

9.  IKKα contributes to canonical NF-κB activation downstream of Nod1-mediated peptidoglycan recognition.

Authors:  Man Lyang Kim; Hyun Gyeong Jeong; Christoph Alexander Kasper; Cécile Arrieumerlou
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

10.  Anthrax lethal toxin enhances IkappaB kinase activation and differentially regulates pro-inflammatory genes in human endothelium.

Authors:  Jason M Warfel; Felice D'Agnillo
Journal:  J Biol Chem       Date:  2009-07-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.